General & Plastic Surgery Devices - Southern Europe

  • Southern Europe
  • The General & Plastic Surgery Devices market market in Southern Europe is anticipated to witness a significant surge in revenue, reaching a projected value of US$1.85bn by the year 2024.
  • This growth trajectory is expected to continue, with an estimated annual growth rate (CAGR 2024-2029) of 4.63%.
  • Consequently, the market volume is forecasted to expand to US$2.32bn by 2029.
  • In comparison to global markets, the United States is projected to generate the highest revenue, with a staggering amount of US$9,844.00m in 2024.
  • In Southern Europe, the demand for General & Plastic Surgery Devices is growing rapidly, driven by the region's high aesthetic consciousness and increasing disposable income.

Key regions: Europe, Japan, United Kingdom, Netherlands, China

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The General & Plastic Surgery Devices market in Southern Europe is experiencing steady growth due to increasing customer preferences for aesthetic procedures, advancements in technology, and rising disposable incomes. Customer preferences in Southern Europe are shifting towards cosmetic surgeries and non-invasive procedures as people strive to enhance their physical appearance. The desire to achieve a youthful and attractive look has led to a rise in demand for plastic surgery devices such as breast implants, facial implants, and liposuction devices. Additionally, the growing popularity of minimally invasive procedures, such as Botox injections and dermal fillers, is also contributing to the growth of the market. Trends in the market include the adoption of innovative technologies and techniques in plastic surgery procedures. Southern European countries are known for their fashion and beauty industries, and as a result, there is a high demand for the latest and most advanced plastic surgery devices. Surgeons are increasingly using robotic-assisted technologies, 3D imaging systems, and laser devices to improve the precision and effectiveness of surgical procedures. These advancements not only enhance patient outcomes but also reduce the recovery time and minimize the risk of complications. Local special circumstances in Southern Europe also contribute to the growth of the General & Plastic Surgery Devices market. Countries in this region, such as Italy and Spain, are popular destinations for medical tourism. Many individuals from other European countries and beyond travel to Southern Europe to undergo cosmetic procedures due to the availability of skilled surgeons, state-of-the-art facilities, and comparatively lower costs. This influx of medical tourists further boosts the demand for plastic surgery devices in the region. Underlying macroeconomic factors, such as rising disposable incomes and increasing healthcare expenditure, are also driving the growth of the General & Plastic Surgery Devices market in Southern Europe. As the economy improves and individuals have more disposable income, they are more likely to invest in aesthetic procedures. Additionally, governments in Southern European countries are increasingly recognizing the economic benefits of medical tourism and are investing in the development of healthcare infrastructure to attract more international patients. In conclusion, the General & Plastic Surgery Devices market in Southern Europe is growing due to changing customer preferences, technological advancements, and favorable macroeconomic factors. The demand for plastic surgery devices is driven by the desire for aesthetic enhancements, the adoption of innovative technologies, the presence of medical tourism, and the improving economic conditions in the region.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

Overview

  • Revenue
  • Key Players
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)